FDA Inspection 1319736 — Zhejiang Huahai Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical Co., Ltd. on Apr 24, 2026 in Linhai. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linhai (China)